There is no specific antidote for overdosage with ENTEREG. Patients should be managed with appropriate supportive therapy. Single doses up to 120 mg and multiple doses up to 48 mg for 7 days have been administered to normal, healthy subjects in clinical studies. In these studies, alvimopan was well tolerated with no discontinuations due to adverse events and no reported serious adverse events or deaths.
ENTEREG is contraindicated in patients who have taken therapeutic doses of opioids for more than 7 consecutive days immediately prior to taking ENTEREG.
Last reviewed on RxList: 12/3/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Entereg Capsules Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.